163 related articles for article (PubMed ID: 16720836)
21. A single amino acid change A91V in perforin: a novel, frequent predisposing factor to childhood acute lymphoblastic leukemia?
Santoro A; Cannella S; Trizzino A; Lo Nigro L; Corsello G; Aricò M
Haematologica; 2005 May; 90(5):697-8. PubMed ID: 15921391
[TBL] [Abstract][Full Text] [Related]
22. A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin.
Trambas C; Gallo F; Pende D; Marcenaro S; Moretta L; De Fusco C; Santoro A; Notarangelo L; Arico M; Griffiths GM
Blood; 2005 Aug; 106(3):932-7. PubMed ID: 15741215
[TBL] [Abstract][Full Text] [Related]
23. A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.
Del-Rey M; Ruiz-Contreras J; Bosque A; Calleja S; Gomez-Rial J; Roldan E; Morales P; Serrano A; Anel A; Paz-Artal E; Allende LM
Blood; 2006 Aug; 108(4):1306-12. PubMed ID: 16627752
[TBL] [Abstract][Full Text] [Related]
24. Perforin-dependent apoptosis functionally compensates Fas deficiency in activation-induced cell death of human T lymphocytes.
Mateo V; Ménager M; de Saint-Basile G; Stolzenberg MC; Roquelaure B; André N; Florkin B; le Deist F; Picard C; Fischer A; Rieux-Laucat F
Blood; 2007 Dec; 110(13):4285-92. PubMed ID: 17724145
[TBL] [Abstract][Full Text] [Related]
25. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation.
Martínez-Feito A; Melero J; Mora-Díaz S; Rodríguez-Vigil C; Elduayen R; González-Granado LI; Pérez-Méndez D; Sánchez-Zapardiel E; Ruiz-García R; Menchén M; Díaz-Madroñero J; Paz-Artal E; Del Orbe-Barreto R; Riñón M; Allende LM
Immunobiology; 2016 Jan; 221(1):40-7. PubMed ID: 26323380
[TBL] [Abstract][Full Text] [Related]
26. The broad spectrum of autoimmune lymphoproliferative disease: molecular bases, clinical features and long-term follow-up in 31 patients.
Campagnoli MF; Garbarini L; Quarello P; Garelli E; Carando A; Baravalle V; Doria A; Biava A; Chiocchetti A; Rosolen A; Dufour C; Dianzani U; Ramenghi U
Haematologica; 2006 Apr; 91(4):538-41. PubMed ID: 16537120
[TBL] [Abstract][Full Text] [Related]
27. Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation.
Dianzani U; Bragardo M; DiFranco D; Alliaudi C; Scagni P; Buonfiglio D; Redoglia V; Bonissoni S; Correra A; Dianzani I; Ramenghi U
Blood; 1997 Apr; 89(8):2871-9. PubMed ID: 9108407
[TBL] [Abstract][Full Text] [Related]
28. FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.
Magerus-Chatinet A; Stolzenberg MC; Loffredo MS; Neven B; Schaffner C; Ducrot N; Arkwright PD; Bader-Meunier B; Barbot J; Blanche S; Casanova JL; Debré M; Ferster A; Fieschi C; Florkin B; Galambrun C; Hermine O; Lambotte O; Solary E; Thomas C; Le Deist F; Picard C; Fischer A; Rieux-Laucat F
Blood; 2009 Mar; 113(13):3027-30. PubMed ID: 19176318
[TBL] [Abstract][Full Text] [Related]
29. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
Taylor MA; Ward B; Schatzle JD; Bennett M
Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
[TBL] [Abstract][Full Text] [Related]
30. A proportion of patients with lymphoma may harbor mutations of the perforin gene.
Clementi R; Locatelli F; Dupré L; Garaventa A; Emmi L; Bregni M; Cefalo G; Moretta A; Danesino C; Comis M; Pession A; Ramenghi U; Maccario R; Aricò M; Roncarolo MG
Blood; 2005 Jun; 105(11):4424-8. PubMed ID: 15728124
[TBL] [Abstract][Full Text] [Related]
31. Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review.
Hafezi N; Zaki-Dizaji M; Nirouei M; Asadi G; Sharifinejad N; Jamee M; Erfan Rasouli S; Hamedifar H; Sabzevari A; Chavoshzadeh Z; Yazdani R; Abolhassani H; Aghamohammadi A; Azizi G
Pediatr Allergy Immunol; 2021 Oct; 32(7):1519-1532. PubMed ID: 33963613
[TBL] [Abstract][Full Text] [Related]
32. Familial hemophagocytic lymphohistiocytosis in an adult patient homozygous for A91V in the perforin gene, with tuberculosis infection.
Mancebo E; Allende LM; Guzmán M; Paz-Artal E; Gil J; Urrea-Moreno R; Fernández-Cruz E; Gayà A; Calvo J; Arbós A; Durán MA; Canet R; Balanzat J; Udina MA; Vercher FJ
Haematologica; 2006 Sep; 91(9):1257-60. PubMed ID: 16956828
[TBL] [Abstract][Full Text] [Related]
33. Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells.
Yanai F; Ishii E; Kojima K; Hasegawa A; Azuma T; Hirose S; Suga N; Mitsudome A; Zaitsu M; Ishida Y; Shirakata Y; Sayama K; Hashimoto K; Yasukawa M
J Immunol; 2003 Feb; 170(4):2205-13. PubMed ID: 12574394
[TBL] [Abstract][Full Text] [Related]
34. Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.
Martin DA; Zheng L; Siegel RM; Huang B; Fisher GH; Wang J; Jackson CE; Puck JM; Dale J; Straus SE; Peter ME; Krammer PH; Fesik S; Lenardo MJ
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4552-7. PubMed ID: 10200300
[TBL] [Abstract][Full Text] [Related]
35. Functional impact of A91V mutation of the PRF1 perforin gene.
Martínez-Pomar N; Lanio N; Romo N; Lopez-Botet M; Matamoros N
Hum Immunol; 2013 Jan; 74(1):14-7. PubMed ID: 23073290
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune lymphoproliferative syndrome, a disorder of apoptosis.
Jackson CE; Puck JM
Curr Opin Pediatr; 1999 Dec; 11(6):521-7. PubMed ID: 10590910
[TBL] [Abstract][Full Text] [Related]
37. Double-negative T cells, activated by xenoantigen, lyse autologous B and T cells using a perforin/granzyme-dependent, Fas-Fas ligand-independent pathway.
Zhang ZX; Ma Y; Wang H; Arp J; Jiang J; Huang X; He KM; Garcia B; Madrenas J; Zhong R
J Immunol; 2006 Nov; 177(10):6920-9. PubMed ID: 17082607
[TBL] [Abstract][Full Text] [Related]
38. Perforin gene mutations in patients with acquired aplastic anemia.
Solomou EE; Gibellini F; Stewart B; Malide D; Berg M; Visconte V; Green S; Childs R; Chanock SJ; Young NS
Blood; 2007 Jun; 109(12):5234-7. PubMed ID: 17311987
[TBL] [Abstract][Full Text] [Related]
39. Autoimmune lymphoproliferative syndrome and perforin.
Rieux-Laucat F; Le Deist F; De Saint Basile G
N Engl J Med; 2005 Jan; 352(3):306-7; author reply 306-7. PubMed ID: 15659737
[No Abstract] [Full Text] [Related]
40. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.
Bleesing JJ; Brown MR; Straus SE; Dale JK; Siegel RM; Johnson M; Lenardo MJ; Puck JM; Fleisher TA
Blood; 2001 Oct; 98(8):2466-73. PubMed ID: 11588044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
